Key result
Multimodality imaging, including transesophageal echocardiography, computed tomography, and 18F-FDG PET-CT, plays a crucial role in accurately diagnosing and managing cardiac device-related infections.
Why the study?
Increasing cardiac device implantations have led to a higher incidence of device-related infections, making accurate diagnosis with multimodality imaging essential for management.
How does multimodality imaging assist in the diagnosis and management of cardiac device-related infections?
How does multimodality imaging assist in the diagnosis and management of cardiac device-related infections?
Multimodality imaging, particularly TEE, CT, and 18F-FDG PET-CT, plays a crucial role in the accurate diagnosis and management planning of cardiac device-related infections.
Answers are grounded in this paper and cite their sources.
Increasing device implantations heighten infection risk; supports multimodality imaging per EHRA consensus but leaves optimal strategies open.
Cardiac devices are frequently used in different cardiovascular conditions for the purpose of morbidity or mortality prevention. These include cardiac implantable electronic devices (CIED) like permanent pacemakers and implantable cardiac defibrillators, ventricular assistance devices (VADs), left atrial appendage occlusion (LAAO) devices like the Watchman™, atrial and ventricular septal occluders like the Amplatzer™, among others. In the past years, there has been an increase in the development of these devices as a result of a rise in the number of indications for implantation, paired with the aging and more medically complex patient population. This has led to an increase in the incidence of cardiac device-related infections, one of the most feared and serious complications which is associated with significant morbidity, mortality and financial burden. Accurate diagnosis of cardiac device-related infections is essential given the management implications which often involve removal of the infected device, removal of other prosthetic material and long-term antimicrobial therapy. Clinical and laboratory data are useful diagnostic tools but multimodality imaging is often necessary. The recently published 2020 European Heart Rhythm Association International Consensus document, which is endorsed by many expert societies, has recommended the use of multimodality imaging for the diagnosis of CIED infections. (1) This allows better disease characterization by identifying abnormal fluid collections and guiding aspiration for both diagnostic and therapeutic purposes (i.e. soft tissue ultrasound and computed tomography), evaluation for local extent of disease (i.e. transesophageal echocardiogram to evaluate for concomitant infective endocarditis), embolic manifestation of disease (i.e. computed tomography and magnetic resonance imaging) and metabolic tissue characterization (positron emission tomography and tagged white blood cell scan). (2) In addition, computed tomography (CT) allows for pre-procedural planning which has shown to be associated with better procedural outcomes.
No takes yet. Share an insight, caveat, or question.
Aguilera et al. (2021) conducted a review in Cardiac device-related infection. Multimodality imaging (Echocardiography, CT, 18F-FDG PET-CT) was evaluated. Multimodality imaging, including transesophageal echocardiography, computed tomography, and 18F-FDG PET-CT, plays a crucial role in accurately diagnosing and managing cardiac device-related infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: